We are live on ! Find out more
KND

Kindred Healthcare
KND

Delisted

KND was delisted on the 29th of June, 2018.

149 hedge funds and large institutions have $700M invested in Kindred Healthcare in 2018 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 44 increasing their positions, 47 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more call options, than puts

Call options by funds: $1.6M | Put options by funds: $841K

6% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 47

7% less capital invested

Capital invested by funds: $755M → $700M (-$55.4M)

10% less funds holding

Funds holding: 166149 (-17)

43% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 37

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
149
Holders Change
-17
Holders Change %
-10.24%
% of All Funds
3.41%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
21
Increased
44
Reduced
47
Closed
37
Calls
$1.6M
Puts
$841K
Net Calls
+$760K
Net Calls Change
+$600K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$115M +$8.48M +946,345 +8%
Vanguard Group
2
Vanguard Group
Pennsylvania
$79.3M +$1.61M +179,347 +2%
BCM
3
Brigade Capital Management
New York
$62M
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$46.8M -$10.5K -1,168 -0%
GLAM
5
Gardner Lewis Asset Management
Pennsylvania
$45.1M +$44.9M +5,009,354 New
WIC
6
Water Island Capital
New York
$32.4M +$4.72M +526,733 +17%
State Street
7
State Street
Massachusetts
$24.2M -$378K -42,238 -2%
JP Morgan Chase
8
JP Morgan Chase
New York
$23.6M -$20.6M -2,304,113 -47%
AA
9
AQR Arbitrage
Connecticut
$21.8M +$18.9M +2,104,671 +674%
GF
10
Gabelli Funds
New York
$16.3M +$5.04M +562,142 +45%
Renaissance Technologies
11
Renaissance Technologies
New York
$16.2M +$12.7M +1,418,600 +368%
Norges Bank
12
Norges Bank
Norway
$14.6M
Charles Schwab
13
Charles Schwab
California
$14.1M +$1.54M +172,211 +12%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$10.1M -$399K -44,556 -4%
Northern Trust
15
Northern Trust
Illinois
$9.65M +$304K +33,893 +3%
GI
16
GAMCO Investors
Connecticut
$7.56M +$2.55M +285,142 +51%
Allianz Asset Management
17
Allianz Asset Management
Germany
$7.43M +$7.4M +826,147 New
Invesco
18
Invesco
Georgia
$7.38M +$2.43M +271,214 +49%
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$7.15M -$1.51M -168,786 -18%
Capital Fund Management (CFM)
20
Capital Fund Management (CFM)
France
$6.76M
Morgan Stanley
21
Morgan Stanley
New York
$6.14M +$4.21M +470,181 +221%
CS
22
Credit Suisse
Switzerland
$6.01M -$176K -19,604 -3%
Millennium Management
23
Millennium Management
New York
$5.67M +$5.65M +630,515 New
GCL
24
Glazer Capital LLC
New York
$4.73M +$4.71M +525,823 New
OAM
25
Oxford Asset Management
United Kingdom
$4.71M +$4.67M +521,000 New

KND Hedge Fund Activity: Q2 2018 in Review

149 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Kindred Healthcare (KND) for Q2 2018, worth a combined $700M — down 7.3% from $755M a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of KND and 21 opened new positions — a net loss of 16 holders — while 47 trimmed existing stakes and 44 added.

The largest buyer was Gardner Lewis Asset Management, opening a new position worth an estimated $44.9M. The largest seller was Deutsche Bank, cutting an estimated $33.5M.

  • 149 institutional investors held Kindred Healthcare (KND) as of Q2 2018, down from 166 in Q1 2018.
  • Funds reported $700M of Kindred Healthcare stock for Q2 2018, down 7.3% quarter-over-quarter.
  • 21 funds opened new Kindred Healthcare positions in Q2 2018 and 37 closed out, a net change of -16 holders.
  • The largest Kindred Healthcare buyer in Q2 2018 was Gardner Lewis Asset Management, an estimated $44.9M added.
  • The largest Kindred Healthcare seller in Q2 2018 was Deutsche Bank, an estimated $33.5M sold.

Based on aggregated 13F filings for Q2 2018.